The price of shortening anti–hepatitis C virus therapy: Is this truly cost saving?

Benzer Materyaller

• The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment
  Yazar:: Lam, Brian P., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• What is the ethical responsibility of a provider when prescribing the new direct‐acting antiviral agents to patients with hepatitis C infection?
  Yazar:: Younossi, Zobair
  Baskı/Yayın Bilgisi: (2015)
• Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan
  Yazar:: Zhuo, Yueran, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Shortening Treatment for Hepatitis C Virus Infection
  Yazar:: Kottilil, Shyam
  Baskı/Yayın Bilgisi: (2018)
• Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes
  Yazar:: Younossi, Zobair M., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)